Genetic drift of influenza A(H3N2) viruses during two consecutive seasons in 2011-2013 in Corsica, France

Journal of Medical Virology

Volumn 86, Issue 4, 2014, Pages 585-591

  Fantoni, Anais ^a,b   Arena, Christophe ^a,c   Corrias, Laura ^d   Salez, Nicolas ^e,f   de Lamballerie, Xavier Nicolas ^e,f   Amoros, Jean Pierre ^a,b   Blanchon, Thierry ^a,g   Varesi, Laurent ^b   Falchi, Alessandra ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE CORSE   (France)

^c Regional Observatory of Health of Corsica   (France)

^d Laboratory of Genetic Populations   (Italy)

^e AIX MARSEILLE UNIVERSITY   (France)

^f INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^g SORBONNE UNIVERSITÉ   (France)

Author keywords

Hemagglutinin; Vaccine effectiveness; Vaccine strain; Virological surveillance

Indexed keywords

HEMAGGLUTININ; VACCINE EFFECTIVENESS; VACCINE STRAIN; VIROLOGICAL SURVEILLANCE;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGENIC VARIATION; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; FRANCE; GENETIC DRIFT; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; SEASONS; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84893735329     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23745     Document Type: Article

References (21)

1. Bonmarin I, Belchior E, Le Strat Y, Levy-Bruhl D. 2012. First estimates of influenza vaccine effectiveness among severe influenza cases, France, 2011/12. Euro Surveill 17:pii: 20163.
2. Bragstad K, Emborg H, Kolsen Fischer T, Voldstedlund M, Gubbels S, Andersen B, Molbak K, Krause T. 2013. Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012/13-A rapid epidemiological and virological assessment. Euro Surveill 18:pii: 20397.
3. Bragstad K, Nielsen LP, Fomsgaard A. 2008. The evolution of human influenza A viruses from 1999 to 2006: A complete genome study. Virol J 5:40.
4. Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM. 1999. Predicting the evolution of human influenza A. Science 286:1921-1925.
5. Chidlow G, Harnett G, Williams S, Levy A, Speers D, Smith DW. 2010. Duplex real-time reverse transcriptase PCR assays for rapid detection and identification of pandemic (H1N1) 2009 and seasonal influenza A/H1, A/H3, and B viruses. J Clin Microbiol 48:862-866.
6. Costagliola D. 1994. When is the epidemic warning cut-off point exceeded? Eur J Epidemiol 10:475-476.
7. Falchi A, Amoros JP, Arena C, Arrighi J, Casabianca F, Andreoletti L, Turbelin C, Flahault A, Blanchon T, Hanslik T, Varesi L. 2011. Genetic structure of human A/H1N1 and A/H3N2 influenza virus on Corsica Island: Phylogenetic analysis and vaccine strain match, 2006-2010. PLoS ONE 6:e24471.
8. Falchi A, Varesi L, Arena C, Leveque N, Renois F, Blanchon T, Amoros JP, Andreoletti L. 2009. Co-circulation of two genetically distinct sub-groups of A/H3N2 influenza strains during the 2006-2007 epidemic season in Corsica Island, France. J Clin Virol 45:265-268.
9. Gupta V, Earl DJ, Deem MW. 2006. Quantifying influenza vaccine efficacy and antigenic distance. Vaccine 24:3881-3888.
10. Huang JW, Yang JM. 2011. Changed epitopes drive the antigenic drift for influenza A (H3N2) viruses. BMC Bioinformatics 12:S31.
11. Kelvin DJ, Farooqui A. 2013. Extremely low vaccine effectiveness against influenza H3N2 in the elderly during the 2012/2013 flu season. J Infect Dev Ctries 7:299-301.
12. Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen J, Nunes B, Pitigoi D, Rizzo C, Rebolledo J, Paradowska-Stankiewicz I, Jimenez-Jorge S, Horvath J, Daviaud I, Guiomar R, Necula G, Bella A, OD J, Gluchowska M, Ciancio B, Nicoll A, Moren A. 2013. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: Results from the I-MOVE multicentre case-control study. Euro Surveill 18:pii: 20390.
13. Lee MS, Chen JS. 2004. Predicting antigenic variants of influenza A/H3N2 viruses. Emerg Infect Dis 10:1385-1390.
14. Munoz ET, Deem MW. 2005. Epitope analysis for influenza vaccine design. Vaccine 23:1144-1148.
15. Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, Holmes EC. 2008. The genomic and epidemiological dynamics of human influenza A virus. Nature 453:615-619.
16. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ. 2008. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 26:D31-D34.
17. Shih AC, Hsiao TC, Ho MS, Li WH. 2007. Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc Natl Acad Sci USA 104:6283-6288.
18. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376.
19. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731-2739.
20. Valleron AJ, Bouvet E, Garnerin P, Menares J, Heard I, Letrait S, Lefaucheux J. 1986. A computer network for the surveillance of communicable diseases: The French experiment. Am J Public Health 76:1289-1292.
21. Wilson IA, Cox NJ. 1990. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 8:737-771.